Logos Global Management LP Delcath Systems, Inc. Transaction History

Logos Global Management LP

  • $1.07 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$2.25 - $4.17 $1.67 Million - $3.1 Million
-744,444 Reduced 71.28%
300,000 $1.25 Million
Q3 2023

Nov 14, 2023
SELL
$3.12 - $5.85 $419,150 - $785,906
-134,343 Reduced 11.4%
1,044,444 $4.23 Million
Q2 2023

Aug 14, 2023
BUY
$5.38 - $7.96 $6.34 Million - $9.38 Million
1,178,787 New
1,178,787 $6.87 Million

Others Institutions Holding DCTH

# of Institutions
62
Shares Held
7.93M
Call Options Held
118K
Put Options Held
69.9K
View Full List

About DELCATH SYSTEMS, INC.

DCTH Quotes by TradingView
  • Ticker DCTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 8,597,680
  • Market Cap $89.1M
  • Description
  • Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...
More about DCTH
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email